TSS:Hg 100571.1

Basic information about the TSS

---

TSS ID: hg_100571.1 Species: human Chr: chr9		Start: 35103178 End: 35103189 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000452248.6 ENST00000619795.4 Distance: -6 GeneID: 30968 HGNC/MGI_ID: HGNC:14559 UniProt_ID: A0A087WYB4 Q9UJZ1

Gene_name: stomatin like 2 Gene_symbol: STOML2 Gene_synonyms: HSPC108 SLP-2 Gene_source: HGNC:14559

TATA-Box annotation

---

Distance to TSS:	11
Nearest PromoterID:	NM_001287033
Entrez ID:	30968
Nearest Unigene:	Hs.3439
Nearest Refseq:	NM_013442
Nearest Ensembl:	ENSG00000165283
Gene Name:	stomatin like 2
Gene Alias:	HSPC108|SLP-2
Gene Description:	stomatin like 2
Gene Type:	protein-coding
CpG%:	0.105
GC%:	0.631841
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@STOML2 p2@STOML2 p3@STOML2
Sample		p1@STOML2	p2@STOML2	p3@STOML2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	104.80	3.12	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	111.28	5.66	2.02
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	97.03	5.59	2.12
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	102.08	4.16	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	101.46	5.62	1.35
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	91.28	9.11	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	134.43	8.93	3.92
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	124.50	9.93	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	142.34	10.69	2.35
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	104.91	7.54	4.06
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	109.55	4.85	2.43
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	93.51	5.69	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	69.64	2.58	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	67.66	3.46	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	65.87	1.76	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	64.38	1.51	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	63.77	1.53	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	59.90	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	46.38	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	63.03	2.71	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	68.56	2.14	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	63.35	3.11	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	63.59	1.81	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	68.19	1.70	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	63.47	3.10	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	61.09	1.90	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	40.66	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	73.79	2.83	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	61.86	3.55	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	56.10	3.08	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	63.85	3.35	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	61.55	1.17	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	62.25	4.01	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	56.57	1.81	2.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	63.39	2.43	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	71.48	1.72	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	78.69	3.88	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	71.93	3.43	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	58.61	4.05	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	54.73	2.16	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	65.87	3.06	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	64.41	3.81	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	57.36	2.95	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	63.64	4.02	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	62.44	2.81	2.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	59.09	2.79	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	65.01	2.88	2.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	52.46	3.58	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	63.67	4.07	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	50.35	2.83	2.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	57.59	4.30	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	71.83	5.34	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	67.42	2.84	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	62.30	3.98	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	34.40	4.19	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	41.79	5.51	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	68.39	6.81	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	70.98	3.53	2.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	49.66	3.77	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	57.11	4.23	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	67.86	3.93	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	32.64	3.18	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	46.21	3.06	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	53.94	2.92	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	59.99	3.55	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	58.01	3.41	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	49.59	1.98	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	40.81	3.28	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	50.67	2.65	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	62.80	4.33	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	58.40	1.83	1.22
Adipocyte - breast, donor1	11376-118A8	51.00	2.06	1.43
Adipocyte - breast, donor2	11327-117E4	46.84	5.13	3.53
Adipocyte - omental, donor1	11473-119C6	43.00	2.54	2.04
Adipocyte - omental, donor2	11474-119C7	49.33	1.49	1.49
Adipocyte - omental, donor3	11475-119C8	58.61	2.01	1.00
Adipocyte - perirenal, donor1	11476-119C9	49.76	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	43.98	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	89.87	5.42	3.61
Adipocyte - subcutaneous, donor3	11408-118E4	80.46	4.34	1.39
Adipocyte differentiation, day04, donor1	13019-139D4	66.49	2.54	1.56
Adipocyte differentiation, day04, donor2	13022-139D7	32.43	0.77	1.29
Adipocyte differentiation, day04, donor3	13025-139E1	51.02	0.84	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	52.32	1.76	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	55.18	5.79	3.06
Adipocyte differentiation, day08, donor2	13023-139D8	44.54	2.26	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	33.06	1.60	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	40.62	5.01	3.34
Adipocyte differentiation, day12, donor1	13021-139D6	49.49	3.74	2.91
Adipocyte differentiation, day12, donor2	13024-139D9	36.67	3.52	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	38.29	2.29	3.60
Adipocyte differentiation, day12, donor4	13030-139E6	30.75	1.83	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	121.99	6.41	3.31
Alveolar Epithelial Cells, donor2	11590-120G6	159.21	7.17	1.79
Alveolar Epithelial Cells, donor3	11671-122G6	69.48	2.40	2.40
Amniotic Epithelial Cells, donor1	11533-120A3	75.92	2.70	1.26
Amniotic Epithelial Cells, donor2	11613-122A2	92.04	3.35	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	75.81	3.08	2.05
Anulus Pulposus Cell, donor1	11248-116E6	80.78	2.52	2.63
Anulus Pulposus Cell, donor2	11463-119B5	46.04	1.47	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	55.71	2.70	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	59.91	0.87	2.17
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	53.51	10.70	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	61.88	0.90	2.69
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	74.61	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	43.56	4.62	3.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	52.96	2.27	1.95
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	49.51	1.94	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	43.95	4.16	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	63.65	2.26	2.26
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	51.52	0.00	2.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	50.15	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	65.40	2.80	2.31
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	62.78	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	53.68	5.43	1.66
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	61.62	2.14	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	51.39	3.40	1.32
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	48.38	6.41	1.87
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	49.75	0.98	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	54.40	3.48	2.49
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	51.63	2.40	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	60.18	10.62	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	53.86	3.77	1.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	46.14	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	64.56	2.43	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	58.81	6.45	2.66
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	44.82	3.63	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	58.14	2.28	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	47.24	4.49	2.35
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	47.75	2.32	2.58
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	65.22	2.82	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	40.52	3.86	3.22
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	55.65	3.57	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	49.14	1.75	2.34
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	51.18	4.52	1.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	68.90	2.38	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	70.69	2.54	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	58.58	2.80	3.31
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	40.03	1.91	4.45
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	51.35	3.88	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	51.44	1.91	2.12
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	44.37	2.61	2.61
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	51.96	3.78	3.78
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	43.91	3.22	2.54
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	37.06	0.00	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	52.81	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	46.31	3.65	2.14
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	52.34	2.41	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	53.94	1.46	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	60.92	4.60	1.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	38.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	54.41	5.34	2.29
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	55.12	3.72	1.86
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	56.61	4.59	1.53
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	57.84	0.96	2.87
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	59.43	3.77	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	38.14	3.05	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	45.42	3.88	2.77
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	50.84	3.18	2.12
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	53.79	2.18	2.91
Astrocyte - cerebellum, donor1	11500-119F6	149.34	6.02	2.70
Astrocyte - cerebellum, donor2	11580-120F5	125.12	3.59	2.74
Astrocyte - cerebellum, donor3	11661-122F5	77.40	2.94	1.89
Astrocyte - cerebral cortex, donor1	11235-116D2	84.01	5.93	4.18
Astrocyte - cerebral cortex, donor2	11316-117D2	103.05	5.82	3.72
Astrocyte - cerebral cortex, donor3	11392-118C6	91.58	5.52	1.79
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	156.09	5.96	4.01
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	172.76	9.02	3.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	154.08	8.65	4.44
Basophils, donor1	12241-129G9	17.26	1.05	0.26
Basophils, donor2	12242-129H1	21.29	0.00	0.72
Basophils, donor3	12243-129H2	24.25	0.73	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	82.58	5.39	2.80
Bronchial Epithelial Cell, donor2	11591-120G7	76.35	5.03	3.20
Bronchial Epithelial Cell, donor3	11672-122G7	100.43	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	133.69	8.16	2.51
Bronchial Epithelial Cell, donor5	11457-119A8	140.37	3.74	1.87
Bronchial Epithelial Cell, donor6	11461-119B3	99.02	2.76	1.61
Bronchial Epithelial Cell, donor7	11769-123I5	70.90	4.14	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	141.39	1.65	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	127.17	3.03	1.63
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	122.47	0.64	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	155.13	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	21.42	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	17.26	0.37	0.00
CD14+ Monocytes, donor3	11381-118B4	21.73	0.22	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	37.93	1.70	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	35.25	0.38	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	29.26	2.63	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	12.72	0.87	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	8.45	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	10.19	0.95	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	9.88	0.17	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	8.28	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	10.41	1.24	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	7.64	0.39	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	7.48	0.71	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	13.06	0.87	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	11.47	0.00	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	12.14	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	13.31	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	10.86	0.89	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	10.58	0.60	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	12.70	0.62	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	8.92	0.00	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	6.79	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	10.48	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	6.46	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	10.82	0.52	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	12.62	0.00	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	6.06	0.55	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.23	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	9.21	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	10.81	0.35	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	10.78	0.74	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	10.78	0.86	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	13.92	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	9.04	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	9.28	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	28.99	1.09	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	31.18	0.92	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	36.61	3.25	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	36.59	1.40	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	30.56	0.87	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	22.97	1.56	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	26.79	1.02	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	24.15	0.88	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	28.42	1.26	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	75.20	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	64.41	2.03	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	75.60	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	61.30	3.20	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	46.10	2.14	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	65.28	2.11	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	76.87	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	84.37	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	34.52	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	33.37	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	30.79	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	155.97	9.29	6.87
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	156.20	13.18	8.39
CD34+ Progenitors, donor1	11545-120B6	63.26	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	42.14	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	151.05	2.25	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	139.80	2.93	1.35
CD4+ T Cells, donor1	11225-116C1	37.85	0.71	0.36
CD4+ T Cells, donor2	11306-117C1	42.87	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	36.90	0.61	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	67.38	1.28	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	77.26	1.35	1.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	71.29	2.59	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	60.21	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	95.52	1.40	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	59.33	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	55.49	1.88	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	68.29	2.88	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	63.84	3.22	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	69.04	0.45	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	76.87	0.70	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	42.68	1.76	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	52.28	0.84	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	69.60	1.87	1.25
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	69.50	3.68	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	54.11	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	47.70	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	64.56	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	68.61	2.04	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	84.26	3.03	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	84.90	3.78	1.68
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	66.23	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	72.79	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	44.45	0.00	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	70.27	2.47	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	63.70	1.85	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	58.62	2.79	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	65.91	2.77	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	60.61	2.70	2.45
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	55.44	3.08	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	61.60	0.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	85.87	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	35.03	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	32.66	0.75	0.00
CD8+ T Cells, donor3	11383-118B6	46.96	1.51	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	139.47	8.03	2.06
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	129.41	7.67	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	119.56	8.75	2.46
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	93.97	5.70	1.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	132.47	6.24	2.64
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	120.06	6.82	1.36
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	164.05	8.47	2.61
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	156.61	12.11	3.68
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	159.94	10.32	3.52
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	177.81	9.36	3.02
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	162.10	8.13	2.32
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	151.33	7.73	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	73.10	5.25	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	77.88	1.37	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	58.92	3.73	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	128.22	9.72	2.52
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	129.76	6.91	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	107.95	6.84	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	167.33	10.14	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	156.24	9.53	2.77
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	135.93	7.37	1.60
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	141.51	7.27	2.68
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	156.85	7.49	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	150.53	4.54	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	111.61	4.01	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	108.41	4.90	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	140.25	3.01	1.00
Cardiac Myocyte, donor1	11525-119I4	18.28	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	100.30	4.94	1.48
Cardiac Myocyte, donor3	11686-122I3	92.29	3.16	2.21
Chondrocyte - de diff, donor1	11261-116G1	72.45	3.47	1.04
Chondrocyte - de diff, donor2	11338-117F6	56.86	2.49	0.36
Chondrocyte - de diff, donor3	11410-118E6	68.04	2.50	1.59
Chondrocyte - re diff, donor2	11339-117F7	42.97	3.58	1.79
Chondrocyte - re diff, donor3	11411-118E7	42.46	0.81	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	100.07	6.20	2.07
Ciliary Epithelial Cells, donor2	11323-117D9	85.72	4.28	2.57
Ciliary Epithelial Cells, donor3	11399-118D4	94.96	3.27	2.30
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	59.15	2.57	2.57
Corneal Epithelial Cells, donor1	11526-119I5	107.59	5.05	3.51
Corneal Epithelial Cells, donor2	11606-120I4	105.80	5.69	2.28
Corneal Epithelial Cells, donor3	11687-122I4	143.15	7.41	2.30
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	21.96	2.81	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	24.60	0.95	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	24.95	2.70	0.86
Dendritic Cells - plasmacytoid, donor1	11228-116C4	57.05	1.02	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	60.72	3.26	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	62.91	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	94.06	4.00	1.50
Endothelial Cells - Aortic, donor1	11263-116G3	78.63	2.93	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	70.98	3.39	1.70
Endothelial Cells - Aortic, donor3	11412-118E8	65.27	2.36	0.39
Endothelial Cells - Artery, donor1	11264-116G4	78.54	3.49	2.04
Endothelial Cells - Artery, donor2	11341-117F9	90.11	2.82	2.35
Endothelial Cells - Artery, donor3	11413-118E9	110.62	3.86	1.58
Endothelial Cells - Lymphatic, donor1	11236-116D3	50.32	1.55	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	43.21	1.52	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	41.16	1.41	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	66.86	1.19	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	124.44	2.60	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	69.19	0.99	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	131.64	2.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	98.54	2.62	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	118.53	3.85	2.36
Endothelial Cells - Umbilical vein, donor2	11324-117E1	83.21	2.82	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	91.23	2.81	0.98
Endothelial Cells - Vein, donor1	11267-116G7	127.40	4.55	0.00
Endothelial Cells - Vein, donor2	11344-117G3	140.40	8.38	2.10
Endothelial Cells - Vein, donor3	11416-118F3	129.37	3.61	0.94
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00
Eosinophils, donor2	12245-129H4	8.25	1.65	0.00
Eosinophils, donor3	12246-129H5	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	93.82	5.13	1.47
Esophageal Epithelial Cells, donor2	11587-120G3	95.69	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	35.30	1.64	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	36.57	2.30	1.64
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	75.08	2.38	1.08
Fibroblast - Aortic Adventitial, donor1	11245-116E3	68.52	2.18	1.94
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	26.48	3.68	1.64
Fibroblast - Aortic Adventitial, donor2	11326-117E3	50.73	2.74	1.79
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	27.93	1.05	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	81.72	1.99	1.66
Fibroblast - Cardiac, donor1	11268-116G8	66.68	2.27	1.36
Fibroblast - Cardiac, donor2	11345-117G4	65.18	2.27	3.03
Fibroblast - Cardiac, donor3	11417-118F4	58.35	2.84	1.42
Fibroblast - Cardiac, donor4	11452-119A3	66.68	2.12	1.52
Fibroblast - Cardiac, donor5	11456-119A7	77.41	3.05	1.14
Fibroblast - Cardiac, donor6	11460-119B2	87.77	3.18	2.12
Fibroblast - Choroid Plexus, donor1	11492-119E7	74.10	1.34	0.94
Fibroblast - Choroid Plexus, donor2	11572-120E6	32.79	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	124.51	7.32	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	183.36	7.15	2.77
Fibroblast - Conjunctival, donor3	11692-122I9	74.29	3.73	1.70
Fibroblast - Dermal, donor1	11269-116G9	100.96	4.93	1.88
Fibroblast - Dermal, donor2	11346-117G5	134.90	5.66	3.30
Fibroblast - Dermal, donor3	11418-118F5	111.82	5.44	1.93
Fibroblast - Dermal, donor4	11450-119A1	114.97	4.75	1.92
Fibroblast - Dermal, donor5	11454-119A5	124.73	4.36	1.22
Fibroblast - Dermal, donor6	11458-119A9	124.90	5.85	2.60
Fibroblast - Gingival, donor1	11237-116D4	67.47	5.21	2.08
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	55.28	2.88	0.79
Fibroblast - Gingival, donor2	11318-117D4	92.91	3.43	2.37
Fibroblast - Gingival, donor3	11394-118C8	72.32	3.48	1.35
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	50.91	4.16	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	39.65	1.59	1.41
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	92.91	4.99	3.12
Fibroblast - Gingival, donor6 (control)	11922-125H5	69.37	3.65	2.84
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	37.41	2.47	1.76
Fibroblast - Gingival, donor7 (control)	11924-125H7	63.91	3.07	2.19
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	59.86	4.23	3.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	64.61	2.74	2.52
Fibroblast - Gingival, donor9 (control)	11927-125I1	42.26	1.61	1.76
Fibroblast - Lung, donor1	11270-116H1	101.95	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	104.45	5.97	0.00
Fibroblast - Lung, donor3	11419-118F6	122.61	7.18	4.01
Fibroblast - Lymphatic, donor1	11506-119G3	170.77	5.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	83.92	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	74.17	4.48	0.84
Fibroblast - Mammary, donor1	11540-120B1	148.18	9.74	3.65
Fibroblast - Mammary, donor2	11620-122A9	155.77	7.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	77.43	5.96	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	98.34	4.07	1.94
Fibroblast - Periodontal Ligament, donor2	11319-117D5	105.87	5.31	1.97
Fibroblast - Periodontal Ligament, donor3	11395-118C9	67.32	5.81	3.37
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	42.74	2.29	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	75.87	3.51	2.70
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	41.63	1.51	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	91.19	5.08	1.88
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	110.33	6.50	4.67
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	121.61	3.34	3.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	86.58	3.56	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	32.15	2.38	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	57.55	2.49	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	72.72	3.94	2.56
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	43.02	3.61	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	78.59	5.29	2.16
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	36.44	2.53	1.01
Fibroblast - skin normal, donor1	11553-120C5	68.58	3.94	2.13
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	31.08	1.80	1.60
Fibroblast - skin normal, donor2	11561-120D4	58.07	3.72	1.61
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	33.25	0.91	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	67.19	3.07	1.99
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	73.34	3.59	1.37
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	34.16	1.64	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	69.77	4.05	1.49
Fibroblast - skin walker warburg, donor1	11554-120C6	90.24	4.89	1.69
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	51.75	3.14	1.25
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	36.60	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	49.41	7.11	2.25
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	66.36	7.03	1.56
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	45.48	6.13	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	186.79	6.12	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	191.42	6.38	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	206.25	7.13	3.42
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	164.08	3.58	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	115.99	5.71	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	165.04	9.11	2.38
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	170.23	5.55	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	133.72	5.22	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	174.24	11.06	3.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	179.90	2.97	1.27
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	143.09	3.08	1.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	135.12	4.57	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	159.95	4.09	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	165.00	4.57	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	111.21	2.85	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	115.23	4.34	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	126.81	2.49	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	88.30	4.59	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	131.78	3.84	2.36
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	140.52	4.13	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	116.63	2.90	1.79
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	105.86	3.43	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	139.11	3.73	1.53
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	113.06	3.90	1.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	111.44	3.12	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	103.66	2.56	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	111.21	2.43	1.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	105.24	3.41	2.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	102.09	2.25	2.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	108.10	4.75	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	129.01	1.84	1.38
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	94.89	3.17	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	89.49	2.65	2.20
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	132.59	2.09	1.11
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	88.34	2.11	1.78
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	98.78	1.60	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	102.62	3.60	1.42
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	92.69	3.48	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	79.37	2.74	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	93.25	2.72	1.67
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	75.75	2.20	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	68.17	3.93	1.68
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	65.09	2.96	1.94
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	70.33	4.01	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	63.50	3.98	1.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	83.29	3.76	1.30
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	66.68	2.17	1.90
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	61.02	3.13	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	58.78	3.29	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	43.64	1.98	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	62.79	2.90	1.32
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	65.37	2.22	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	46.51	3.30	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	177.36	3.38	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	170.10	2.77	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	195.17	5.52	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	196.21	6.26	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	179.99	6.50	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	126.37	3.69	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	227.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	187.22	4.64	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	215.00	12.84	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	156.49	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	152.65	4.88	2.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	142.07	7.41	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	126.63	10.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	156.04	4.19	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	146.75	4.90	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	147.64	5.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	166.99	5.41	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	159.64	5.77	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	210.90	4.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	197.01	6.30	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	146.22	6.22	2.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	182.97	10.16	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	187.64	6.63	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	151.65	3.91	1.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	168.59	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	154.53	4.61	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	143.43	3.91	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	162.53	4.01	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	170.29	2.31	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	133.85	1.37	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	156.54	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	167.51	2.36	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	181.65	4.83	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	158.71	2.54	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	173.49	2.39	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	146.03	4.93	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	169.98	4.72	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	179.12	3.50	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	170.29	4.39	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	117.83	4.24	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	118.79	2.98	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	128.11	1.94	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	59.35	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	46.57	2.49	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	136.06	4.50	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	54.55	2.22	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	50.13	3.76	2.51
Hep-2 cells mock treated, biol_rep1	11898-125E8	99.80	6.15	2.67
Hep-2 cells mock treated, biol_rep2	11899-125E9	105.16	6.41	2.53
Hep-2 cells mock treated, biol_rep3	11900-125F1	99.87	5.92	1.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	107.67	7.21	2.62
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	109.39	7.09	2.79
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	90.20	5.81	2.15
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	101.75	6.60	3.36
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	92.98	5.66	2.23
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	87.14	5.13	1.60
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	91.22	1.12	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	81.80	3.03	2.16
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	97.82	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	102.29	3.53	2.47
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	79.19	5.09	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	103.68	4.72	1.40
Hepatocyte, donor1	11523-119I2	81.11	4.84	1.21
Hepatocyte, donor2	11603-120I1	81.88	8.62	3.23
Hepatocyte, donor3	11684-122I1	78.53	3.07	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	99.86	3.26	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	133.01	5.42	2.27
Iris Pigment Epithelial Cells, donor1	11530-119I9	73.82	4.39	3.02
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	156.01	12.74	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	120.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	243.75	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	134.28	8.31	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	157.67	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	154.29	11.87	23.74
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	161.46	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	132.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	183.55	9.75	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	136.72	5.00	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	134.33	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	176.02	7.94	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	129.71	9.98	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	151.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	160.62	8.19	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	154.66	6.19	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	146.35	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	174.43	7.75	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	149.72	8.05	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	155.33	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	182.53	11.41	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	186.82	8.40	3.78
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	114.98	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	152.70	5.63	3.21
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	121.87	1.85	4.62
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	105.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	168.05	7.55	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	113.37	4.53	4.53
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	176.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	192.63	9.69	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	146.10	15.25	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	161.97	8.29	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	209.61	9.11	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	161.38	5.71	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	172.55	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	145.94	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	150.63	6.17	1.85
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	165.07	12.29	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	163.44	9.43	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	164.81	2.09	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	208.03	6.64	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	168.58	6.48	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	167.41	6.10	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	177.73	20.25	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	160.29	3.48	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	171.75	8.53	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	142.70	5.54	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	145.33	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	208.94	10.12	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	139.16	9.08	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	117.96	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	169.18	5.29	1.06
Keratinocyte - epidermal, donor1	11272-116H3	40.80	3.59	1.22
Keratinocyte - epidermal, donor2	11349-117G8	103.66	4.69	1.76
Keratinocyte - epidermal, donor3	11421-118F8	112.45	6.15	2.08
Keratinocyte - oral, donor1	11251-116E9	135.77	5.90	3.52
Keratocytes, donor1	11527-119I6	204.92	7.91	4.13
Keratocytes, donor2	11607-120I5	124.21	3.52	3.52
Keratocytes, donor3	11688-122I5	65.01	3.56	1.38
Krukenberg tumor cell line:HSKTC	10687-109F3	103.30	10.99	2.20
Lens Epithelial Cells, donor1	11529-119I8	81.98	4.31	2.16
Lens Epithelial Cells, donor2	11609-120I7	100.45	4.50	3.23
Lens Epithelial Cells, donor3	11690-122I7	38.35	3.03	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	85.38	3.08	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	88.19	1.95	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	91.30	1.42	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	80.12	1.61	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	70.91	1.58	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	83.34	2.48	0.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	71.41	1.23	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	101.89	2.28	1.52
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	74.03	1.13	1.27
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	66.05	2.37	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	78.33	1.74	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	87.02	1.67	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	70.38	0.70	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	90.40	1.43	1.43
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	77.46	1.37	1.37
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	75.14	1.54	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	94.15	2.81	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	92.78	1.28	0.91
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	87.87	1.65	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	98.11	3.81	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	103.55	1.24	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	79.53	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	87.25	2.69	1.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	88.25	2.12	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	72.06	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	85.43	2.51	1.26
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	78.95	1.65	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	75.67	2.06	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	82.03	1.88	1.51
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	79.84	1.27	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	73.17	1.94	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	74.43	1.98	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	81.15	1.12	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	74.41	1.85	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	87.47	1.48	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	84.28	1.10	1.37
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	76.87	1.93	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	81.26	1.83	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	79.08	2.66	1.12
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	78.93	1.78	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	87.74	1.94	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	98.66	2.33	1.40
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	93.11	2.86	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	88.53	1.31	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	93.70	2.12	1.41
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	78.09	3.71	0.99
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	85.55	1.79	1.54
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	73.99	3.28	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	67.98	4.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	95.12	10.74	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	77.19	3.71	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	91.40	2.96	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	86.51	7.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	82.19	1.87	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	67.50	3.61	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	79.69	3.57	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	94.55	5.88	1.81
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	73.87	0.87	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	82.83	3.60	2.70
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	102.02	4.74	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	80.62	5.14	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	84.33	2.82	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	62.63	2.67	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	89.65	1.53	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	88.31	3.74	2.13
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	75.01	6.42	1.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	87.13	3.07	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	91.33	4.89	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	73.51	5.00	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	76.79	2.52	2.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	100.97	4.12	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	69.96	4.35	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	78.62	5.68	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	68.60	4.43	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	85.54	2.47	2.47
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	86.29	4.43	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	100.16	4.61	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	89.03	5.37	3.07
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	91.71	6.23	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	86.15	1.64	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	97.15	4.52	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	89.05	3.59	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	88.13	5.98	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	95.50	4.83	2.23
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	80.98	3.88	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	105.32	5.14	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	104.28	5.66	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	84.46	2.41	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	98.12	2.13	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	88.68	4.47	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	94.47	2.68	2.68
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	90.90	3.37	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	99.64	4.44	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	82.57	3.49	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	95.20	4.23	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	96.84	5.20	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	86.50	1.45	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	117.28	6.13	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	97.18	0.49	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	77.16	0.94	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	100.56	5.03	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	99.14	1.80	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	80.89	5.16	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	92.63	4.90	2.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	86.81	5.08	2.35
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	73.89	3.30	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	104.30	3.63	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	88.39	3.50	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	72.68	2.24	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	108.20	6.62	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	84.09	4.63	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	69.88	2.03	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	96.12	2.40	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	72.75	4.37	2.39
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	74.13	3.04	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	68.48	3.46	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	91.96	4.56	2.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	81.08	3.61	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	85.26	5.44	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	89.68	3.80	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	93.29	1.60	3.20
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	84.48	2.30	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	98.73	3.09	3.60
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	82.76	4.24	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	88.53	4.54	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	105.25	3.33	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	73.61	4.70	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	103.55	3.34	2.09
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	103.15	6.04	3.25
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	90.32	1.34	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	103.72	2.67	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	100.62	3.64	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	84.43	7.34	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	104.91	3.56	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	96.88	5.13	2.85
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	100.46	4.60	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	109.98	1.64	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	102.01	6.68	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	115.68	5.20	3.38
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	120.69	4.64	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	116.40	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	24.61	0.91	0.68
Macrophage - monocyte derived, donor2	11313-117C8	21.47	2.39	0.92
Macrophage - monocyte derived, donor3	11389-118C3	25.43	2.10	1.05
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	70.63	6.37	2.66
Mallassez-derived cells, donor2	11929-125I3	34.54	2.54	1.90
Mallassez-derived cells, donor3	11930-125I4	55.18	5.42	1.95
Mammary Epithelial Cell, donor1	11273-116H4	107.02	5.88	2.59
Mammary Epithelial Cell, donor2	11350-117G9	109.74	4.92	2.03
Mammary Epithelial Cell, donor3	11422-118F9	108.50	6.73	3.74
Mast cell - stimulated, donor1	11487-119E2	75.25	2.03	2.03
Mast cell, donor1	11563-120D6	87.59	2.49	2.05
Mast cell, donor2	11565-120D8	91.23	3.57	1.78
Mast cell, donor3	11566-120D9	114.81	4.73	4.95
Mast cell, donor4	11567-120E1	76.41	2.13	1.60
Mast cell, expanded and stimulated, donor5	11940-126A5	64.32	2.66	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	50.20	1.75	0.00
Mast cell, expanded, donor5	11939-126A4	108.87	3.79	2.18
Mast cell, expanded, donor8	11941-126A6	72.80	2.68	1.34
Melanocyte - dark, donor1	11502-119F8	106.66	1.69	1.59
Melanocyte - dark, donor2	11582-120F7	88.94	2.77	0.69
Melanocyte - dark, donor3	11663-122F7	79.61	3.91	1.74
Melanocyte - light, donor1	11274-116H5	53.60	5.41	1.65
Melanocyte - light, donor2	11351-117H1	72.34	6.82	0.68
Melanocyte - light, donor3	11423-118G1	52.03	2.60	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	104.96	4.89	2.39
Melanocyte, donor2 (MC+2)	12739-135I3	74.50	5.11	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	64.02	6.43	4.82
Meningeal Cells, donor1	11493-119E8	137.58	4.59	1.24
Meningeal Cells, donor2	11573-120E7	99.03	5.72	1.76
Meningeal Cells, donor3	11654-122E7	101.88	4.56	2.85
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	115.77	4.56	4.28
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	52.53	3.82	1.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	57.82	1.31	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	122.97	14.39	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	137.06	12.20	4.31
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	53.37	3.18	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	65.85	4.02	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	137.13	7.03	3.52
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	130.04	4.38	4.38
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	120.72	6.96	1.64
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	75.76	1.94	1.39
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	71.74	4.09	2.97
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	71.18	3.29	1.32
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	61.43	2.67	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	74.74	9.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	135.76	4.48	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	163.04	14.18	7.09
Mesenchymal stem cells - hepatic, donor0	11218-116B3	77.87	1.88	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	162.55	5.81	5.81
Mesothelial Cells, donor1	11247-116E5	32.09	5.30	1.86
Mesothelial Cells, donor2	12156-128G5	27.53	4.00	3.00
Mesothelial Cells, donor3	11402-118D7	32.59	3.83	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	17.55	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	22.66	3.45	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	27.38	2.06	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	22.94	2.48	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	20.54	2.49	1.45
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	23.02	2.25	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	23.74	2.79	2.79
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	25.40	2.64	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	22.97	1.19	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	30.97	0.88	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	27.36	1.52	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	25.68	1.49	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	15.65	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	16.10	1.19	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	21.58	1.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	17.83	2.85	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.29	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	18.65	1.15	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	14.93	2.52	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	14.68	1.02	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	19.52	2.36	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	9.34	1.56	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	17.30	0.88	1.75
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	8.62	0.51	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	12.23	1.36	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	12.94	1.47	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	15.86	1.92	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	19.61	2.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	22.53	1.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	20.58	0.88	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	6.62	2.21	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	18.35	2.73	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	7.65	2.09	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	8.84	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	28.38	2.39	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	11.38	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	10.65	0.36	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	23.85	1.12	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	13.72	1.25	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.91	1.17	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	24.13	2.41	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	18.78	2.92	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	20.32	1.85	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	17.07	1.71	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	11.88	1.11	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	20.99	2.85	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.87	0.86	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	6.99	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	15.48	1.60	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	17.66	1.80	1.80
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.43	0.99	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	26.44	2.55	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	15.92	1.99	1.11
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	13.65	1.52	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	19.89	3.13	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	19.91	2.95	1.72
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.08	0.65	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	16.47	2.06	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	17.59	2.31	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	10.72	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	17.27	2.08	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	64.04	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	26.73	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	36.47	3.94	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	26.30	4.21	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	27.28	2.97	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	18.63	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	25.16	0.75	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	30.36	1.86	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	25.79	2.49	1.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	22.10	2.21	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	31.15	1.83	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	3.11	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	17.64	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	35.35	5.05	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	21.08	1.26	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	10.90	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.27	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	7.29	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	57.95	2.37	3.23
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	52.78	1.57	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	47.39	2.00	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	50.92	1.67	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	51.34	4.18	1.52
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	67.03	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	37.40	2.72	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	33.08	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	53.99	2.51	2.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	63.22	5.81	3.25
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	41.34	2.16	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	44.15	1.47	1.68
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	46.66	1.99	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	35.73	3.79	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	47.38	2.49	1.36
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	41.32	2.12	1.31
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	39.37	1.64	1.64
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	42.97	0.53	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	28.81	1.80	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	19.36	0.98	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	36.59	1.30	2.11
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	32.63	2.12	1.23
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	51.34	1.41	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	44.59	2.30	2.30
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	53.02	3.21	1.93
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	25.18	2.76	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	7.59	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	38.99	1.78	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	50.38	2.54	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	30.38	1.42	1.42
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	58.81	5.15	2.15
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	47.98	2.00	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	32.01	2.25	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	42.46	3.17	2.38
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	39.93	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	46.16	3.41	3.03
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	40.41	2.28	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	32.25	0.87	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	33.92	1.36	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	28.22	2.65	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	50.53	1.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	42.16	1.49	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	37.52	1.15	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	61.70	3.33	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	26.30	2.87	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	34.56	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	68.28	2.44	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	34.31	2.83	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	37.83	1.82	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	41.93	2.37	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	22.67	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	0.00	0.00
Myoblast, donor1	11241-116D8	44.23	6.34	2.86
Myoblast, donor2	11322-117D8	74.22	3.64	2.30
Myoblast, donor3	11398-118D3	66.42	3.53	3.20
NK T cell leukemia cell line:KHYG-1	10777-110G3	92.81	2.48	1.61
Natural Killer Cells, donor1	11230-116C6	33.83	0.31	0.62
Natural Killer Cells, donor2	11311-117C6	37.39	0.90	0.00
Natural Killer Cells, donor3	11387-118C1	34.05	1.47	0.37
Neural stem cells, donor1	11275-116H6	51.54	3.63	3.27
Neural stem cells, donor2	11352-117H2	73.17	0.00	1.93
Neurons, donor1	11494-119E9	79.65	1.14	2.28
Neurons, donor2	11574-120E8	67.59	3.52	1.54
Neurons, donor3	11655-122E8	68.24	2.47	1.64
Neutrophils, donor1	11233-116C9	1.86	0.93	0.93
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	3.05	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	64.00	1.42	1.31
Nucleus Pulposus Cell, donor2	11409-118E5	74.56	1.95	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	73.80	3.41	1.80
Olfactory epithelial cells, donor1	11933-125I7	41.57	1.65	0.69
Olfactory epithelial cells, donor2	11934-125I8	49.79	2.32	1.59
Olfactory epithelial cells, donor3	11935-125I9	47.45	2.61	1.25
Olfactory epithelial cells, donor4	11936-126A1	39.93	1.56	1.46
Oligodendrocyte - precursors, donor1	11496-119F2	81.85	5.42	1.20
Osteoblast - differentiated, donor1	11276-116H7	50.62	3.40	1.28
Osteoblast - differentiated, donor2	11353-117H3	61.73	6.86	1.14
Osteoblast - differentiated, donor3	11425-118G3	91.24	2.48	0.62
Osteoblast, donor1	11277-116H8	160.45	4.89	2.15
Osteoblast, donor2	11354-117H4	90.60	5.62	2.11
Osteoblast, donor3	11426-118G4	105.04	4.27	2.84
Pancreatic stromal cells, donor1	11249-116E7	75.73	5.31	2.53
Pericytes, donor1	11491-119E6	83.34	0.89	0.56
Pericytes, donor2	11571-120E5	78.78	2.26	2.04
Pericytes, donor3	11652-122E5	100.91	5.29	2.64
Perineurial Cells, donor1	11499-119F5	84.31	3.96	1.13
Perineurial Cells, donor2	11579-120F4	85.48	4.23	1.75
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	23.27	0.64	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	24.73	0.73	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	26.92	1.16	0.13
Placental Epithelial Cells, donor1	11278-116H9	187.51	9.57	6.46
Placental Epithelial Cells, donor2	11355-117H5	100.91	2.22	1.11
Placental Epithelial Cells, donor3	11427-118G5	102.88	2.16	1.37
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	37.02	1.58	1.90
Preadipocyte - breast, donor1	11467-119B9	38.64	2.25	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	19.58	1.83	1.44
Preadipocyte - breast, donor2	11328-117E5	47.06	2.25	2.25
Preadipocyte - omental, donor1	11468-119C1	40.28	2.66	1.60
Preadipocyte - omental, donor2	11329-117E6	42.77	0.87	0.87
Preadipocyte - omental, donor3	11403-118D8	49.28	2.15	1.15
Preadipocyte - perirenal, donor1	11469-119C2	67.91	0.98	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	129.60	8.91	4.61
Preadipocyte - subcutaneous, donor2	11356-117H6	133.52	9.21	2.66
Preadipocyte - subcutaneous, donor3	11428-118G6	111.20	5.62	1.87
Preadipocyte - visceral, donor1	11280-116I2	96.31	6.71	3.17
Preadipocyte - visceral, donor2	11357-117H7	72.71	4.60	2.76
Preadipocyte - visceral, donor3	11429-118G7	84.64	3.76	2.19
Prostate Epithelial Cells (polarized), donor1	11253-116F2	95.79	6.79	2.26
Prostate Epithelial Cells, donor2	11331-117E8	34.67	3.11	2.03
Prostate Epithelial Cells, donor3	11404-118D9	40.29	3.18	2.02
Prostate Stromal Cells, donor1	11254-116F3	88.73	7.18	2.51
Prostate Stromal Cells, donor2	11332-117E9	100.41	6.81	3.05
Prostate Stromal Cells, donor3	11405-118E1	61.42	4.17	1.98
Renal Cortical Epithelial Cells, donor1	11516-119H4	121.17	7.30	2.19
Renal Cortical Epithelial Cells, donor2	11596-120H3	59.40	5.13	2.15
Renal Epithelial Cells, donor1	11517-119H5	130.36	5.07	1.52
Renal Epithelial Cells, donor2	11597-120H4	116.66	12.09	0.71
Renal Epithelial Cells, donor3	11678-122H4	66.38	4.98	2.43
Renal Glomerular Endothelial Cells, donor1	11514-119H2	83.06	2.04	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	119.27	3.64	1.35
Renal Glomerular Endothelial Cells, donor3	11675-122H1	65.49	4.22	1.78
Renal Glomerular Endothelial Cells, donor4	11783-124B1	71.87	2.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	122.37	6.60	1.98
Renal Mesangial Cells, donor2	11598-120H5	110.35	5.64	1.88
Renal Mesangial Cells, donor3	11679-122H5	104.31	4.44	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	130.45	8.59	1.88
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	100.36	8.01	4.22
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	111.08	6.36	2.89
Retinal Pigment Epithelial Cells, donor0	11215-116A9	121.60	7.52	4.15
Retinal Pigment Epithelial Cells, donor1	11528-119I7	86.98	4.83	4.83
Retinal Pigment Epithelial Cells, donor2	11608-120I6	112.17	6.17	5.15
Retinal Pigment Epithelial Cells, donor3	11689-122I6	76.53	6.02	3.76
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	50.11	3.07	1.87
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	35.74	1.79	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	18.71	2.20	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	23.20	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	52.40	4.03	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	60.58	3.38	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	72.95	4.68	2.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	85.09	5.46	2.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	73.54	3.85	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	73.27	4.62	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	56.00	3.42	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	56.12	3.63	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	73.83	6.45	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	66.13	2.73	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	70.29	3.86	2.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	69.92	2.88	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	43.59	1.91	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	52.64	3.63	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	67.46	6.95	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	43.66	1.86	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	56.17	3.60	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	76.96	5.16	2.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	50.30	3.10	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	53.82	5.33	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	62.21	3.42	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	48.50	1.09	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	71.00	3.92	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	80.19	5.51	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	61.09	3.30	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	60.12	3.17	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	68.28	4.44	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	65.52	2.90	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	46.90	1.99	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	71.44	3.13	3.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	64.74	4.85	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	46.49	2.21	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	61.31	1.54	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	65.51	2.75	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	48.28	3.15	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	61.24	4.76	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	47.55	1.70	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	81.97	3.99	2.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	48.78	2.93	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	51.71	2.77	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	80.00	4.05	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	55.02	3.02	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	61.50	2.54	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	64.98	1.40	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	51.07	2.42	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	68.17	3.18	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	50.94	2.47	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	77.88	4.26	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	68.72	1.81	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	68.54	2.71	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	54.52	3.00	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	65.77	2.83	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	78.76	3.84	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	53.49	2.40	2.40
Schwann Cells, donor1	11498-119F4	133.34	3.20	1.50
Schwann Cells, donor2	11578-120F3	105.47	0.00	0.00
Schwann Cells, donor3	11659-122F3	83.47	3.51	1.75
Sebocyte, donor1	11220-116B5	107.36	3.83	1.10
Sebocyte, donor2	11301-117B5	67.55	6.43	0.92
Sebocyte, donor3	11378-118B1	86.98	3.09	3.09
Sertoli Cells, donor1	11255-116F4	79.52	3.31	0.00
Sertoli Cells, donor2	11333-117F1	67.78	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	116.92	1.94	1.58
Skeletal Muscle Cells, donor2	11358-117H8	91.08	1.45	1.45
Skeletal Muscle Cells, donor3	11430-118G8	156.34	5.85	1.67
Skeletal Muscle Cells, donor4	11451-119A2	147.35	7.54	3.46
Skeletal Muscle Cells, donor5	11455-119A6	147.01	6.39	3.72
Skeletal Muscle Cells, donor6	11459-119B1	161.75	8.31	4.16
Skeletal Muscle Satellite Cells, donor1	11240-116D7	108.24	3.15	2.52
Skeletal Muscle Satellite Cells, donor2	11321-117D7	108.59	4.99	1.28
Skeletal Muscle Satellite Cells, donor3	11397-118D2	155.66	8.33	3.67
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	76.08	3.71	1.85
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	140.41	2.90	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	82.01	3.44	1.51
Skin - palm, donor1	10286-104F7	40.29	2.69	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	60.83	3.60	2.74
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	53.16	3.27	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	65.69	4.15	1.56
Small Airway Epithelial Cells, donor1	11256-116F5	52.82	2.92	3.06
Small Airway Epithelial Cells, donor2	11334-117F2	41.78	1.69	1.41
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	71.47	3.38	2.11
Small Airway Epithelial Cells, donor3	11406-118E2	39.50	3.30	1.57
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	64.19	4.94	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	16.45	1.33	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	86.41	7.05	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	61.44	1.99	2.21
Smooth Muscle Cells - Aortic, donor2	11360-117I1	87.81	3.94	3.54
Smooth Muscle Cells - Aortic, donor3	11432-118H1	88.07	1.55	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	93.07	2.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	59.35	3.99	2.26
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	65.61	2.22	1.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	61.07	3.71	1.41
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	59.26	2.28	1.95
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	68.22	5.02	2.66
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	52.39	6.12	2.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	98.91	6.67	3.42
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	38.36	2.13	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	90.17	2.53	1.26
Smooth Muscle Cells - Carotid, donor2	11362-117I3	165.26	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	77.25	2.38	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	78.01	4.28	1.03
Smooth Muscle Cells - Colonic, donor2	11320-117D6	74.69	3.66	1.51
Smooth Muscle Cells - Colonic, donor3	11396-118D1	95.83	6.51	3.57
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	77.80	3.87	3.25
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	64.67	2.16	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	68.14	4.18	1.79
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	118.81	12.97	2.73
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	82.85	2.67	1.73
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	40.56	4.13	1.41
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	43.24	5.01	1.82
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	71.85	1.21	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	161.34	9.80	5.30
Smooth Muscle Cells - Prostate, donor1	11257-116F6	89.88	3.86	1.73
Smooth Muscle Cells - Prostate, donor2	11335-117F3	76.76	5.13	3.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	53.27	2.79	2.03
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	79.31	4.22	2.41
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	63.01	2.25	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	178.33	3.88	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	82.32	5.12	3.72
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	52.51	2.52	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	42.31	2.19	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	64.90	5.90	2.36
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	116.38	5.66	2.75
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	56.53	4.20	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	63.18	4.89	1.30
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	103.26	4.84	2.04
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	108.12	3.76	1.69
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	93.49	4.89	2.79
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	89.23	3.69	2.18
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	98.09	2.86	3.33
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	52.36	4.16	1.96
Smooth Muscle Cells - Uterine, donor1	11258-116F7	77.55	3.31	3.09
Smooth Muscle Cells - Uterine, donor3	11466-119B8	86.02	5.27	3.22
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	32.07	0.97	1.75
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	30.15	1.32	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	16.74	1.12	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	38.09	3.59	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	48.55	5.11	2.27
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	72.08	2.36	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	30.98	1.02	1.78
Smooth muscle cells - airway, control, donor2	11967-126D5	34.34	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	36.37	2.09	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	62.34	2.29	0.46
Synoviocyte, donor1	11291-117A4	42.25	3.20	0.84
Synoviocyte, donor2	11368-117I9	59.51	1.68	2.18
Synoviocyte, donor3	11440-118H9	41.33	1.34	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	172.23	7.15	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	93.16	7.93	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	102.11	3.47	2.55
Tracheal Epithelial Cells, donor1	11292-117A5	98.35	4.52	1.94
Tracheal Epithelial Cells, donor2	11369-118A1	118.67	5.41	1.55
Tracheal Epithelial Cells, donor3	11441-118I1	112.81	5.73	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	57.33	2.34	2.46
Urethra, donor2	10319-105A4	34.17	1.80	1.80
Urothelial Cells, donor1	11520-119H8	73.06	5.58	3.45
Urothelial Cells, donor2	11600-120H7	83.32	4.81	2.40
Urothelial Cells, donor3	11681-122H7	80.68	5.96	2.52
Urothelial cells, donor0	11216-116B1	81.13	6.69	3.57
Whole blood (ribopure), donor090309, donation1	12179-129A1	53.39	6.23	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	65.76	4.29	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	37.65	2.74	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	37.88	4.48	2.07
Whole blood (ribopure), donor090325, donation2	12177-128I8	37.77	5.81	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	52.06	1.04	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	56.90	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	39.25	3.65	0.91
Wilms' tumor cell line:G-401	10809-111A8	177.27	10.73	4.32
Wilms' tumor cell line:HFWT	10597-108E3	84.48	3.52	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	64.24	2.79	1.68
achilles tendon, donor2	10292-104G4	35.13	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	129.77	2.55	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	146.04	4.18	1.39
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	104.94	2.49	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	210.89	6.80	3.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	168.09	2.53	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	134.92	2.33	1.69
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	111.61	2.18	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	151.58	2.64	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	141.29	2.45	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	137.07	2.33	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	218.04	7.36	2.39
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	109.21	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	163.13	4.65	2.79
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	209.45	6.73	2.59
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	177.98	4.09	1.75
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	127.34	2.79	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	90.89	7.40	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	135.98	32.54	8.29
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	96.44	29.87	8.11
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	90.38	23.05	6.37
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	112.89	27.44	6.98
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	196.46	4.01	1.56
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	107.07	7.34	3.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	117.07	1.86	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	235.04	6.78	3.77
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	69.78	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	168.70	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	118.46	9.42	2.83
adipose tissue, adult, pool1	10010-101C1	38.00	2.17	0.93
adipose, donor1	10184-103D4	116.11	5.28	1.17
adipose, donor2	10185-103D5	100.57	3.65	1.62
adipose, donor3	10186-103D6	107.28	3.81	2.45
adipose, donor4	10187-103D7	149.95	7.80	4.33
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	98.64	6.00	2.68
adrenal gland, adult, pool1	10081-102A9	72.75	14.55	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	74.97	2.67	1.33
alveolar cell carcinoma cell line:SW 1573	10708-109H6	131.84	7.86	3.93
amniotic membrane cells, donor1	12235-129G3	39.18	2.09	0.93
amniotic membrane cells, donor2	12236-129G4	83.17	1.69	2.03
amniotic membrane cells, donor3	12237-129G5	35.65	2.36	1.18
amygdala - adult, donor10196	10167-103B5	40.32	4.74	1.19
amygdala, adult, donor10252	10151-102I7	36.09	2.43	2.23
amygdala, newborn, donor10223	10360-105E9	20.33	2.26	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	133.82	5.73	3.06
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	317.70	9.93	5.29
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	89.19	3.34	0.33
aorta, adult, pool1	10052-101G7	39.23	0.78	0.59
appendix, adult	10189-103D9	59.77	1.94	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	117.63	6.19	2.06
artery, adult	10190-103E1	116.85	1.36	4.08
astrocytoma cell line:TM-31	10425-106D2	69.83	2.46	1.01
b cell line:RPMI1788	10427-106D4	125.95	2.53	2.23
basal cell carcinoma cell line:TE 354.T	10702-109G9	42.45	3.61	2.50
bile duct carcinoma cell line:HuCCT1	10432-106D9	109.35	5.36	2.58
bile duct carcinoma cell line:TFK-1	10496-107C1	52.05	3.68	1.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	107.37	2.80	1.68
bladder, adult, pool1	10011-101C2	38.68	1.96	0.76
blood, adult, pool1	10053-101G8	50.94	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	17.98	0.00	0.00
bone marrow, adult	10192-103E3	35.77	2.02	0.00
brain, adult, donor1	10084-102B3	37.93	3.08	1.03
brain, adult, pool1	10012-101C3	35.52	1.11	0.89
brain, fetal, pool1	10085-102B4	58.77	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	41.63	1.32	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	108.72	4.87	3.00
breast, adult, donor1	10080-102A8	34.09	2.53	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	124.12	5.08	1.40
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	123.38	8.04	1.86
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	58.48	4.83	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	41.64	3.63	1.69
carcinoid cell line:NCI-H1770	10703-109H1	148.57	9.87	3.76
carcinoid cell line:NCI-H727	10735-110B6	58.30	2.84	0.98
carcinoid cell line:SK-PN-DW	10719-109I8	120.74	4.44	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	142.41	5.06	2.40
caudate nucleus - adult, donor10196	10177-103C6	23.03	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	36.98	3.51	1.67
caudate nucleus, adult, donor10258	10379-105H1	42.03	2.29	0.00
caudate nucleus, newborn, donor10223	10354-105E3	24.54	3.66	1.10
cerebellum - adult, donor10196	10173-103C2	40.79	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	44.84	1.49	2.56
cerebellum, adult, pool1	10083-102B2	48.29	1.38	0.69
cerebellum, newborn, donor10223	10357-105E6	40.68	0.83	0.00
cerebral meninges, adult	10188-103D8	30.26	1.51	0.25
cerebrospinal fluid, donor2	10294-104G6	35.08	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	115.03	4.03	2.30
cervical cancer cell line:ME-180	10553-107I4	128.93	6.30	2.65
cervix, adult, pool1	10013-101C4	47.46	1.26	0.94
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	64.79	4.46	2.65
chondrosarcoma cell line:SW 1353	10700-109G7	36.58	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	113.59	3.85	1.74
choriocarcinoma cell line:SCH	10785-110H2	101.90	2.59	1.60
choriocarcinoma cell line:T3M-3	10618-108G6	113.13	9.25	3.56
chorionic membrane cells, donor1	12238-129G6	49.01	0.85	0.57
chorionic membrane cells, donor2	12239-129G7	70.80	3.78	1.69
chorionic membrane cells, donor3	12240-129G8	59.34	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	146.42	2.02	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	132.55	4.03	1.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	104.54	2.75	2.32
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	86.29	6.16	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	100.38	3.87	2.90
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	88.77	6.11	1.22
chronic myelogenous leukemia cell line:K562	10454-106G4	205.53	13.25	3.53
chronic myelogenous leukemia cell line:KU812	10409-106B4	107.12	5.21	1.82
clear cell carcinoma cell line:JHOC-5	10638-108I8	94.86	4.11	0.46
clear cell carcinoma cell line:TEN	10636-108I6	43.20	2.26	1.56
colon carcinoma cell line:CACO-2	10513-107D9	164.37	11.53	2.93
colon carcinoma cell line:COLO-320	10420-106C6	193.08	4.56	0.38
colon, adult, donor1	10082-102B1	111.86	4.76	1.19
colon, adult, pool1	10014-101C5	62.04	2.70	2.59
colon, fetal, donor1	10070-101I7	39.55	0.62	1.24
common myeloid progenitor CMP, donor1	12130-128D6	137.51	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	200.29	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	131.30	11.90	2.97
cord blood derived cell line:COBL-a 24h infection	10453-106G3	165.27	10.11	3.77
cord blood derived cell line:COBL-a untreated	10449-106F8	195.02	10.72	4.65
corpus callosum, adult, pool1	10042-101F6	49.09	3.43	1.33
cruciate ligament, donor2	10295-104G7	38.90	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	56.98	2.41	0.00
diencephalon, adult	10193-103E4	36.72	2.40	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	158.20	2.53	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	116.42	7.44	5.13
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	112.18	8.67	6.50
ductus deferens, adult	10196-103E7	32.89	1.50	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	72.01	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	66.94	2.94	0.00
dura mater, adult, donor1	10041-101F5	54.51	1.65	1.16
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	108.37	8.66	3.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	125.24	6.88	4.59
embryonic pancreas cell line:1B2C6	10604-108F1	69.68	3.70	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	89.00	6.96	3.94
embryonic pancreas cell line:1C3IKEI	10606-108F3	68.23	7.10	2.16
embryonic pancreas cell line:2C6	10603-108E9	85.38	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	86.82	4.36	1.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	102.94	3.99	3.26
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	78.16	9.01	3.86
epidermoid carcinoma cell line:A431	10426-106D3	95.26	4.45	2.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	114.93	7.81	3.30
epididymis, adult	10197-103E8	48.14	1.47	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	20.22	1.24	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	57.81	9.83	2.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	90.03	6.29	3.67
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	86.22	4.92	2.17
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	100.15	6.61	3.25
esophagus, adult, pool1	10015-101C6	51.50	3.40	1.17
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	98.69	3.88	2.25
eye - muscle inferior rectus, donor1	10272-104E2	26.56	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	31.56	0.00	0.00
eye - muscle medial, donor2	10299-104H2	59.53	0.00	0.00
eye - muscle superior, donor2	10297-104G9	35.54	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	18.95	0.00	0.00
eye, fetal, donor1	10054-101G9	53.39	1.02	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	114.25	4.23	1.80
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	96.63	5.94	4.27
frontal lobe, adult, pool1	10040-101F4	49.45	2.35	1.78
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	103.89	2.40	2.10
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	67.66	4.02	1.55
gall bladder, adult	10198-103E9	61.81	3.62	2.90
gamma delta positive T cells, donor1	11937-126A2	69.79	1.61	0.00
gamma delta positive T cells, donor2	11938-126A3	45.19	2.61	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	117.65	7.82	2.96
gastric adenocarcinoma cell line:MKN45	10612-108F9	94.58	7.54	3.09
gastric cancer cell line:AZ521	10549-107H9	158.71	16.40	9.35
gastric cancer cell line:GSS	10560-108A2	122.64	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	95.04	0.91	0.46
giant cell carcinoma cell line:LU65	10487-107B1	202.75	19.62	15.83
giant cell carcinoma cell line:Lu99B	10433-106E1	125.82	7.28	4.34
glassy cell carcinoma cell line:HOKUG	10688-109F4	83.31	6.73	1.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	35.78	1.58	1.58
glioblastoma cell line:A172, tech_rep2	10444-106F3	37.50	1.12	0.98
glioblastoma cell line:T98G	10485-107A8	82.45	3.20	1.66
glioma cell line:GI-1	10413-106B8	111.59	5.27	4.39
globus pallidus - adult, donor10196	10175-103C4	25.51	2.19	0.00
globus pallidus, adult, donor10252	10161-103A8	42.23	1.46	1.46
globus pallidus, adult, donor10258	10367-105F7	28.75	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	28.24	2.66	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	200.67	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	196.71	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	219.52	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	42.56	2.88	1.28
hIPS +CCl2, biol_rep1	14383-156B9	117.99	4.13	2.30
hIPS +CCl2, biol_rep2	14384-156C1	108.83	3.66	1.83
hIPS +CCl2, biol_rep3	14385-156C2	138.48	2.58	0.00
hIPS, biol_rep1	14380-156B6	99.17	4.31	0.00
hIPS, biol_rep2	14381-156B7	159.12	6.86	0.00
hIPS, biol_rep3	14382-156B8	45.24	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	125.57	3.74	3.74
heart - mitral valve, adult	10205-103F7	37.37	0.60	0.60
heart - pulmonic valve, adult	10206-103F8	54.39	1.05	1.05
heart - tricuspid valve, adult	10207-103F9	50.79	1.67	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	67.13	6.73	3.88
heart, adult, diseased, donor1	10051-101G6	102.63	6.39	2.13
heart, adult, pool1	10016-101C7	83.94	6.44	2.30
heart, fetal, pool1	10046-101G1	81.43	1.95	1.75
hepatic mesenchymal tumor cell line:LI90	10778-110G4	36.41	1.85	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	82.05	5.95	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	169.28	10.94	4.53
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	192.98	10.68	5.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	188.87	12.13	5.36
hepatoma cell line:Li-7	10484-107A7	126.01	3.67	2.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	179.69	6.93	3.12
hippocampus - adult, donor10196	10169-103B7	26.50	1.89	0.95
hippocampus, adult, donor10252	10153-102I9	36.94	2.25	2.04
hippocampus, adult, donor10258	10374-105G5	31.87	2.99	0.00
hippocampus, newborn, donor10223	10363-105F3	28.20	1.06	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	179.44	8.54	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	161.40	7.46	1.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	165.54	6.60	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	156.19	3.38	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	132.46	2.84	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	171.20	3.42	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	114.45	3.80	2.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	128.40	6.68	3.02
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	119.28	6.67	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	159.84	10.66	4.97
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	130.98	4.66	2.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	151.49	6.06	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	154.29	7.67	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	159.67	10.32	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	128.29	8.73	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	144.71	5.92	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	146.08	4.80	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	121.94	7.50	3.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	113.60	4.33	1.70
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	116.86	5.46	2.73
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	98.36	4.70	2.51
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	111.05	5.06	2.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	113.51	4.94	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	109.70	3.59	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	155.00	4.99	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	157.76	3.99	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	172.31	10.21	3.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	129.92	5.63	2.46
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	128.60	3.17	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	152.82	6.36	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	110.66	4.65	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	120.88	5.98	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	102.10	4.87	3.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	105.58	6.90	3.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	133.27	6.06	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	120.31	6.39	3.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	165.67	7.25	1.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	162.67	5.79	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	142.44	7.80	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	143.64	4.89	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	120.37	6.51	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	131.38	5.30	1.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	141.75	7.66	4.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	123.40	7.24	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	118.51	5.34	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	108.60	9.55	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	136.64	8.67	4.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	105.60	7.27	1.89
immature langerhans cells, donor1	11904-125F5	27.85	0.97	0.48
immature langerhans cells, donor2	11905-125F6	31.69	0.00	0.79
insula, adult, pool1	10039-101F3	49.87	2.93	1.04
keratoacanthoma cell line:HKA-1	10791-110H8	184.68	14.31	7.15
kidney, adult, pool1	10017-101C8	66.68	6.21	3.20
kidney, fetal, pool1	10045-101F9	78.09	2.76	1.98
large cell lung carcinoma cell line:IA-LM	10509-107D5	63.63	1.99	0.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	72.44	2.21	1.24
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	71.75	1.10	1.28
left atrium, adult, donor1	10079-102A7	48.49	2.18	0.54
left ventricle, adult, donor1	10078-102A6	66.75	3.03	1.01
leiomyoblastoma cell line:G-402	10721-110A1	96.31	5.20	3.28
leiomyoma cell line:10964C	10569-108B2	48.14	4.31	1.08
leiomyoma cell line:15242A	10570-108B3	34.24	3.26	3.80
leiomyoma cell line:15425	10571-108B4	44.44	4.86	3.40
leiomyosarcoma cell line:Hs 5.T	10722-110A2	88.89	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	85.74	2.09	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	133.05	2.36	1.89
liposarcoma cell line:KMLS-1	10782-110G8	34.21	2.81	0.62
liposarcoma cell line:SW 872	10726-110A6	99.18	2.31	0.85
liver, adult, pool1	10018-101C9	89.62	7.29	3.57
liver, fetal, pool1	10086-102B5	48.92	4.70	1.88
locus coeruleus - adult, donor10196	10182-103D2	19.83	1.17	0.58
locus coeruleus, adult, donor10252	10165-103B3	34.51	1.48	1.48
locus coeruleus, adult, donor10258	10375-105G6	39.50	1.97	1.41
locus coeruleus, newborn, donor10223	10362-105F2	18.51	2.52	0.42
lung adenocarcinoma cell line:A549	10499-107C4	77.50	2.91	1.11
lung adenocarcinoma cell line:PC-14	10408-106B3	48.26	2.76	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	76.19	3.16	1.05
lung, adult, pool1	10019-101D1	35.20	1.18	0.83
lung, fetal, donor1	10068-101I5	61.36	1.14	0.86
lung, right lower lobe, adult, donor1	10075-102A3	32.53	2.75	0.92
lymph node, adult, donor1	10077-102A5	46.39	0.95	0.47
lymphangiectasia cell line:DS-1	10727-110A7	91.18	1.97	1.32
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	95.54	2.87	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	41.63	3.40	4.25
mature adipocyte, donor1	12231-129F8	68.82	3.55	2.66
mature adipocyte, donor2	12232-129F9	61.64	5.81	1.66
mature adipocyte, donor3	12233-129G1	58.08	3.56	2.37
mature adipocyte, donor4	12234-129G2	53.70	2.11	2.11
maxillary sinus tumor cell line:HSQ-89	10414-106B9	101.26	5.72	3.81
medial frontal gyrus - adult, donor10196	10170-103B8	42.87	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	30.90	2.02	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	41.93	1.27	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	15.78	2.99	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	33.41	1.35	1.52
medial temporal gyrus, adult, donor10252	10156-103A3	38.41	1.70	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	36.60	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	24.77	0.36	0.72
medulla oblongata - adult, donor10196	10174-103C3	30.50	2.60	1.30
medulla oblongata, adult, donor10252	10155-103A2	38.39	3.10	1.55
medulla oblongata, adult, pool1	10038-101F2	39.34	1.06	0.98
medulla oblongata, newborn, donor10223	10361-105F1	40.27	2.43	0.69
medulloblastoma cell line:D283 Med	10838-111E1	163.62	2.44	0.22
medulloblastoma cell line:ONS-76	10759-110E3	103.08	2.08	1.83
melanoma cell line:COLO 679	10514-107E1	79.49	4.02	2.87
melanoma cell line:G-361	10465-106H6	59.45	2.71	1.63
meningioma cell line:HKBMM	10691-109F7	95.16	2.89	2.89
merkel cell carcinoma cell line:MKL-1	10843-111E6	122.48	2.64	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	143.87	4.67	2.59
mesenchymal precursor cell - adipose, donor1	11747-123G1	120.75	6.44	3.68
mesenchymal precursor cell - adipose, donor2	11748-123G2	94.53	4.73	1.27
mesenchymal precursor cell - adipose, donor3	11749-123G3	83.65	2.90	2.07
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	66.16	2.39	1.97
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	58.73	4.24	2.12
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	69.41	0.00	3.47
mesenchymal precursor cell - cardiac, donor1	11752-123G6	52.18	2.57	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	66.13	4.49	2.42
mesenchymal precursor cell - cardiac, donor3	11754-123G8	79.98	4.77	2.25
mesenchymal precursor cell - cardiac, donor4	11755-123G9	82.78	4.86	2.03
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	62.88	3.70	2.99
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	48.09	1.98	1.98
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	66.00	3.74	1.11
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	60.04	2.09	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	63.50	4.08	1.63
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	41.70	3.59	1.80
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	49.45	3.72	2.28
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	27.81	3.42	1.60
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	99.44	8.39	3.36
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	70.39	4.93	2.54
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	55.93	4.64	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	46.76	1.10	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	33.77	4.58	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	82.52	5.05	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	62.56	2.74	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	64.97	2.56	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	65.18	2.88	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	66.85	4.01	3.70
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	56.49	1.88	1.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	73.78	2.03	3.38
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	61.70	5.11	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	63.48	1.39	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	74.70	4.33	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	64.25	2.90	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	65.86	3.85	1.92
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	45.47	2.20	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	59.75	4.36	2.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	61.41	2.87	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	59.28	3.44	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	62.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	67.14	25.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	66.58	4.55	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	72.75	2.91	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	89.56	2.13	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	78.51	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	63.36	2.33	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	60.86	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	67.56	1.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	68.78	2.96	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	86.51	0.00	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	60.80	1.90	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	74.15	3.79	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	81.67	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	43.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	99.87	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	64.38	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	67.53	1.59	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	58.36	3.54	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	67.02	2.18	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	61.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	83.97	3.55	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	69.34	2.57	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	91.56	4.82	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	81.15	6.43	3.96
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	60.56	13.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	78.24	5.09	5.72
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	85.03	9.67	4.43
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	76.32	15.26	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	81.09	8.87	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	94.07	8.50	4.25
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	108.46	18.08	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	66.72	9.88	4.12
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	56.75	3.77	1.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	52.24	3.24	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	57.04	6.11	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	32.50	2.32	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	100.40	6.85	4.72
mesothelioma cell line:ACC-MESO-4	10494-107B8	94.99	3.01	2.32
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	68.38	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	51.58	2.26	1.44
mesothelioma cell line:Mero-25	10850-111F4	130.50	4.77	2.27
mesothelioma cell line:Mero-41	10851-111F5	113.44	5.62	4.65
mesothelioma cell line:Mero-48a	10852-111F6	205.71	10.85	6.64
mesothelioma cell line:Mero-82	10853-111F7	135.08	3.42	1.58
mesothelioma cell line:Mero-83	10854-111F8	144.35	6.64	4.09
mesothelioma cell line:Mero-84	10855-111F9	62.69	2.02	0.25
mesothelioma cell line:Mero-95	10856-111G1	69.57	3.52	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	104.69	3.81	1.49
mesothelioma cell line:NCI-H226	10846-111E9	53.75	1.99	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	57.23	1.88	2.05
mesothelioma cell line:NCI-H28	10845-111E8	84.99	8.40	4.58
mesothelioma cell line:No36	10857-111G2	135.05	5.87	3.26
mesothelioma cell line:ONE58	10858-111G3	65.57	2.44	0.54
migratory langerhans cells, donor1	11901-125F2	24.37	1.92	1.15
migratory langerhans cells, donor2	11902-125F3	37.25	2.81	2.32
migratory langerhans cells, donor3	11903-125F4	50.79	2.33	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	101.21	6.53	3.92
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	92.40	5.72	1.91
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	97.21	5.07	2.53
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	89.82	3.23	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	199.58	10.72	3.88
myeloma cell line:PCM6	10474-106I6	80.85	2.17	1.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	54.79	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	67.47	1.96	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	69.97	4.90	2.90
nasal epithelial cells, donor1, tech_rep2	12226-129F3	59.20	4.19	2.72
nasal epithelial cells, donor2	12227-129F4	94.39	2.76	1.66
neuroblastoma cell line:CHP-134	10508-107D4	168.86	1.38	0.92
neuroblastoma cell line:NB-1	10539-107G8	157.34	2.62	2.81
neuroblastoma cell line:NBsusSR	10607-108F4	188.75	4.85	1.27
neuroblastoma cell line:NH-12	10555-107I6	176.85	2.61	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	87.30	0.95	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	97.56	4.91	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	125.99	5.64	2.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	106.81	1.27	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	56.96	1.60	0.80
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	145.44	1.18	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	152.10	3.20	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	61.56	2.56	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	54.66	3.42	1.05
nucleus accumbens, adult, pool1	10037-101F1	41.62	1.78	1.31
occipital cortex - adult, donor10196	10172-103C1	32.97	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	31.13	1.34	0.81
occipital cortex, newborn, donor10223	10355-105E4	23.66	1.46	0.36
occipital lobe, adult, donor1	10076-102A4	39.62	1.31	1.57
occipital lobe, fetal, donor1	10073-102A1	32.61	3.43	2.15
occipital pole, adult, pool1	10036-101E9	50.70	1.89	1.26
olfactory region, adult	10195-103E6	34.77	1.72	0.96
optic nerve, donor1	10277-104E7	34.02	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	103.77	4.56	2.28
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	136.70	8.93	2.47
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	79.75	4.57	1.35
oral squamous cell carcinoma cell line:SAS	10544-107H4	127.52	4.39	2.19
osteoclastoma cell line:Hs 706.T	10704-109H2	56.44	1.18	2.35
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	154.17	2.80	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	84.19	5.51	2.12
ovary, adult, pool1	10020-101D2	55.12	1.66	0.70
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	61.23	2.57	1.65
pancreas, adult, donor1	10049-101G4	81.84	0.00	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	86.38	5.59	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	126.40	5.45	1.70
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	83.12	6.79	2.81
paracentral gyrus, adult, pool1	10035-101E8	44.66	1.83	1.10
parietal cortex, adult, donor10258	10373-105G4	42.57	2.20	0.73
parietal lobe - adult, donor10196	10171-103B9	30.10	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	31.64	1.71	0.86
parietal lobe, adult, pool1	10034-101E7	45.12	2.11	0.53
parietal lobe, fetal, donor1	10072-101I9	32.00	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	22.81	1.87	0.00
parotid gland, adult	10199-103F1	64.13	1.85	1.23
penis, adult	10200-103F2	53.71	1.07	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	82.74	2.79	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	63.52	2.91	2.04
pineal gland - adult, donor10196	10179-103C8	11.61	2.58	0.65
pineal gland, adult, donor10252	10160-103A7	36.72	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	25.71	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	40.47	2.02	1.01
pituitary gland, adult, donor10252	10162-103A9	42.74	5.73	6.25
pituitary gland, adult, donor10258	10378-105G9	34.05	2.55	0.85
placenta, adult, pool1	10021-101D3	47.30	2.47	1.08
plasma cell leukemia cell line:ARH-77	10840-111E3	120.91	2.78	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	65.06	2.65	0.47
pons, adult, pool1	10033-101E6	39.33	2.15	2.24
postcentral gyrus, adult, pool1	10032-101E5	50.47	3.23	1.74
promyelocytes/myelocytes PMC, donor1	12132-128D8	179.86	8.37	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	110.16	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	129.09	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	219.08	15.44	5.97
prostate cancer cell line:PC-3	10439-106E7	97.47	4.36	2.54
prostate, adult, pool1	10022-101D4	46.43	2.09	2.09
putamen, adult, donor10196	10176-103C5	38.01	2.12	1.18
putamen, adult, donor10252	10152-102I8	27.45	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	50.27	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	34.07	0.97	0.48
putamen, newborn, donor10223	10365-105F5	10.50	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	82.33	10.76	5.53
rectum, fetal, donor1	10067-101I4	59.81	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	50.46	2.54	2.76
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	23.61	2.49	0.00
retina, adult, pool1	10030-101E3	59.74	1.39	0.50
retinoblastoma cell line:Y79	10475-106I7	136.14	2.34	1.82
rhabdomyosarcoma cell line:KYM-1	10787-110H4	138.07	10.20	5.04
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	90.83	2.25	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	50.78	2.27	1.52
salivary acinar cells, donor1	11771-123I7	76.07	2.59	0.65
salivary acinar cells, donor2	11772-123I8	70.08	1.38	0.55
salivary acinar cells, donor3	11773-123I9	48.99	1.32	1.32
salivary gland, adult, pool1	10093-102C3	76.07	0.57	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	82.46	11.04	4.22
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	87.81	12.23	7.05
seminal vesicle, adult	10201-103F3	48.15	2.65	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	61.95	2.92	1.70
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	129.34	7.80	4.28
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	213.75	16.06	7.02
serous cystadenocarcinoma cell line:HTOA	10693-109F9	82.07	2.55	2.15
signet ring carcinoma cell line:Kato III	10436-106E4	123.24	8.07	5.19
signet ring carcinoma cell line:NUGC-4	10483-107A6	181.54	9.81	2.58
skeletal muscle - soleus muscle, donor1	10282-104F3	48.23	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	80.00	2.40	0.84
skeletal muscle, fetal, donor1	10066-101I3	74.37	3.02	1.01
skin, adult, donor1	10074-102A2	40.71	0.00	0.00
skin, fetal, donor1	10065-101I2	59.97	1.89	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	113.40	4.00	4.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	134.59	0.95	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	118.73	7.32	4.05
small cell lung carcinoma cell line:LK-2	10541-107H1	151.81	2.97	0.99
small cell lung carcinoma cell line:NCI-H82	10842-111E5	142.03	1.77	1.29
small cell lung carcinoma cell line:WA-hT	10562-108A4	74.09	1.31	0.65
small intestine, adult, pool1	10024-101D6	81.94	8.36	3.82
small intestine, fetal, donor1	10064-101I1	66.83	10.07	2.70
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	82.06	1.03	2.05
smooth muscle, adult, pool1	10048-101G3	41.35	1.29	0.52
somatostatinoma cell line:QGP-1	10781-110G7	62.18	2.14	1.88
spinal cord - adult, donor10196	10181-103D1	14.22	0.92	0.69
spinal cord, adult, donor10252	10159-103A6	28.78	1.18	1.97
spinal cord, adult, donor10258	10369-105F9	24.90	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	55.50	0.61	1.22
spinal cord, newborn, donor10223	10359-105E8	27.55	6.43	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	39.58	2.09	0.90
spleen, adult, pool1	10025-101D7	40.97	1.65	0.22
spleen, fetal, pool1	10044-101F8	51.88	1.43	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	72.46	2.48	0.72
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	72.72	6.08	2.85
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	55.21	10.48	4.54
squamous cell carcinoma cell line:T3M-5	10616-108G4	113.76	5.08	3.52
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	47.50	3.71	2.03
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	246.11	5.93	2.12
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	74.04	4.23	1.27
stomach, fetal, donor1	10062-101H8	63.01	10.68	3.20
submaxillary gland, adult	10202-103F4	55.26	2.28	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	40.92	1.87	1.25
substantia nigra, adult, donor10258	10371-105G2	31.04	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	22.61	2.12	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	143.06	8.48	3.44
temporal lobe, adult, pool1	10031-101E4	52.81	2.97	2.12
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	44.16	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	45.71	0.44	0.44
tenocyte, donor1	11763-123H8	68.07	2.79	2.44
tenocyte, donor2	11765-123I1	62.57	1.14	1.53
tenocyte, donor3	11768-123I4	61.90	3.71	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	243.89	10.20	2.89
teratocarcinoma cell line:NCR-G1	10798-110I6	229.68	12.18	3.24
teratocarcinoma cell line:PA-1	10807-111A6	163.35	4.80	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	124.15	5.59	2.03
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	150.51	1.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	135.67	4.58	1.96
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	131.91	3.26	1.63
testis, adult, pool1	10026-101D8	60.13	3.22	1.40
testis, adult, pool2	10096-102C6	65.86	4.96	2.71
thalamus - adult, donor10196	10168-103B6	20.98	2.21	0.00
thalamus, adult, donor10252	10154-103A1	33.29	2.19	1.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	30.79	1.54	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	28.49	1.65	1.15
thalamus, newborn, donor10223	10366-105F6	8.05	1.73	0.58
throat, adult	10209-103G2	65.41	3.75	0.75
throat, fetal, donor1	10061-101H7	65.21	1.83	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	167.93	6.76	3.97
thymus, adult, pool1	10027-101D9	65.71	0.80	0.50
thymus, fetal, pool1	10043-101F7	55.17	1.87	1.25
thyroid carcinoma cell line:KHM-5M	10776-110G2	75.79	2.66	1.73
thyroid carcinoma cell line:TCO-1	10783-110G9	280.08	14.25	7.12
thyroid, adult, pool1	10028-101E1	69.98	4.76	1.49
thyroid, fetal, donor1	10060-101H6	47.46	1.58	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	43.11	0.00	0.00
tongue, adult	10203-103F5	66.98	9.77	1.86
tongue, fetal, donor1	10059-101H5	89.46	2.36	0.79
tonsil, adult, pool1	10047-101G2	74.73	3.21	1.60
trachea, adult, pool1	10029-101E2	58.65	3.93	1.23
trachea, fetal, donor1	10058-101H4	63.47	3.08	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	81.13	4.25	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	114.29	6.18	2.53
transitional-cell carcinoma cell line:JMSU1	10492-107B6	89.00	7.36	2.19
tridermal teratoma cell line:HGRT	10694-109G1	45.66	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	77.46	2.79	1.95
umbilical cord, fetal, donor1	10057-101H3	43.82	6.26	0.00
uterus, adult, pool1	10100-102D1	55.45	0.68	0.85
uterus, fetal, donor1	10055-101H1	75.25	1.02	0.51
vagina, adult	10204-103F6	30.37	1.94	0.65
vein, adult	10191-103E2	50.63	1.32	1.32
xeroderma pigentosum b cell line:XPL 17	10563-108A5	87.86	2.67	2.40